Mosaic Aneuploidy in Human Pluripotent Stem Cells
Author Information
Author(s): Suzanne E. Peterson, Jurjen W. Westra, Stevens K. Rehen, Holly Young, Diane M. Bushman, Christine M. Paczkowski, Yun C. Yung, Candace L. Lynch, Ha T. Tran, Kyle S. Nickey, Yu-Chieh Wang, Louise C. Laurent, Jeanne F. Loring, Melissa K. Carpenter, Jerold Chun
Primary Institution: The Scripps Research Institute
Hypothesis
Do normal human pluripotent stem cell lines exhibit mosaic aneuploidy?
Conclusion
Normal human pluripotent stem cell lines contain significant levels of mosaic aneuploidy, which may contribute to their functional and phenotypic heterogeneity.
Supporting Evidence
- All examined hPSC lines exhibited mosaic aneuploidy ranging from 18% to 35%.
- Mosaic aneuploidy was independent of culture conditions.
- Mosaic aneuploidy persisted over time in culture.
- FISH analysis confirmed significant levels of aneuploidy in hPSC lines compared to lymphocytes.
- Mosaic aneuploidy may contribute to the functional and phenotypic heterogeneity of hPSCs.
Takeaway
The study found that human stem cells are not all the same; they have different numbers of chromosomes, which is normal and helps them work better.
Methodology
The study analyzed multiple hPSC lines for mosaic aneuploidy using chromosome counting, spectral karyotyping (SKY), and fluorescent in situ hybridization (FISH).
Potential Biases
Potential bias in the interpretation of aneuploidy as an artifact due to conventional cytogenetic practices.
Limitations
The study does not address the long-term implications of mosaic aneuploidy on stem cell functionality and safety in therapeutic applications.
Participant Demographics
Human pluripotent stem cell lines derived from various sources.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website